|
|
Scanning electron micrograph of the head of a female Anopheles
gambiae mosquito, indicating the olfactory appendages (antennae,
maxillary palps and proboscis)
|
|
Courtesy of LJ Zwiebel, colorization by Dominic Doyle / Vanderbilt
University
|
Leslie Vosshall thought she had it nailed. Last March, she and two colleagues
at Rockefeller University published an elegant series of experiments that seemed to
settle the 50-year-old question of how the insect repellent DEET kept mosquitoes at
bay (Science, 319:1838-42, 2008). "It doesn't smell bad to insects,"
Vosshall told a reporter from Science, "It masks or inhibits their
ability to smell you."
It was a public victory for Vosshall's lab and her funder, the Bill &
Melinda Gates Foundation. As the gold standard of insect repellents, understanding
how and why DEET works so well is critical to designing the next generation of
chemicals, which may head off insect-borne diseases such as malaria and dengue
fever. Behind the scenes, however, some entomologists expressed puzzlement.
Laurence Zwiebel of Vanderbilt University (also a Gates' grantee) says he
remained circumspect when a reporter asked his opinion of Vosshall's research.
Ulrich Bernier of the US Department of Agriculture simply declined to comment. To
them, the findings just didn't make sense, given everything they knew about this
system.
Leslie Vosshall thought she had it nailed.
In her experiment, Vosshall had measured the response of the mosquito's
olfactory neurons to two separate, attractive odors in human breath. Then, she
combined each odorant with DEET in a single odor cartridge and noticed a smaller
neural response. Vosshall interpreted these data to mean that DEET was blocking the
mosquito's olfactory co-receptor.
When Walter Leal's lab at the University of California at Davis made the same
observation two years earlier, however, he reasoned that since DEET was highly
volatile, it might be preventing other odors from vaporizing and exiting the
cartridge—not, as Vosshall believed, blocking the olfactory co-receptor. Using gas
chromatography, Leal confirmed his suspicions this year. When he repeated Vosshall's
experiment using separate odor cartridges that blended DEET and each attractive odor
only at their tips, the mosquito's neural response was no longer diminished. Then,
Leal identified a DEET-sensitive odor receptor neuron and showed that mosquitoes
avoid passing through a "curtain" of DEET vapors. In September 2008, Leal and
Zainulabeuddin Syed published their rebuttal (PNAS 105:13598-603,
2008). Their theory: "Mosquitoes smell and avoid the insect repellent DEET."
Leal's paper surprised Vosshall, who first got wind of it when a reporter at
The New York Times asked for her comment. "I loved our
Science paper," she says, when I visit her 11th floor office one
rainy Friday afternoon in late September. Vosshall is unconvinced by Leal's results,
and has been trying to reproduce the effect in her own lab. "Competition in science
is good," she says, "It can be difficult when it's a small field, and this is a very
small field."
With a lab full of Drosophila mutants, Vosshall is a relative
outsider in an arena dominated by rubber-boot-wearing field entomologists. ("We're
not working on a model system," Zwiebel likes to boast, "We're working on
the system.") In 1994, Vosshall first cloned the fruit fly's olfactory
co-receptor, called OR83b, and in the ten years that followed she discovered that
it was coupled to odor-specific receptors in every olfactory neuron, convincing her
it was a key element in insect repellent strategies. Mutant flies without OR83b
couldn't smell anything.
Genomic studies have since shown that this co-receptor is found in insects
ranging from mosquitoes to moths, and in 2005, as part of the Gates Grand Challenge
to eradicate malaria, she began looking for a chemical that could block the
co-receptors, making humans invisible to insects. Using tissue cultures, she has
adopted the philosophy of targeted drug discovery to screen 91,520 compounds from a
chemical library, short-listing about 150 that she believes have the potential to be
insect "confusants."
In her office, Vosshall pulls up a slide showing the effect of compound #209,
which she says is 100-200 times more potent than DEET in blocking OR83b in one
particular tissue assay. Part of the controversy, Vosshall says, stems from the fact
that DEET is a "messy molecule" with a potential for multiple interactions. Indeed,
even Vosshall's skeptics admit the confusant strategy is fundamentally sound.
Zwiebel says his unpublished molecular work confirms the existence of confusants,
but when it comes to DEET, he and Vosshall aren't willing to budge. "We have agreed
to disagree on the DEET story," he says.